Ticker Symbol: DMAC
DiaMedica Therapeutics Inc
$4.05 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001401040
Company Profile
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.diamedica.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.31
Change:
-$0.17
(
-6.83%)
Days Range: $2.22 - $2.50
Beta: 0.63
52wk. High: $4.75
52wk. Low: $1.12
Ytd. Change 50.76%
50 Day Moving Average: $2.70
200 Day Moving Average: $2.77
Shares Outstanding: 37949422
Valuation
Market Cap: 8.8B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A